These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11482316)

  • 1. [Experimental studies of the value of SPIO for MRI of bone marrow before and after whole body irradiation].
    Daldrup-Link HE; Reinländer C; Link TM; Richter KJ; Könemann S; Rummeny EJ
    Rofo; 2001 Jun; 173(6):547-53. PubMed ID: 11482316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring radiation-induced changes in bone marrow histopathology with ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI.
    Daldrup HE; Link TM; Blasius S; Strozyk A; Könemann S; Jürgens H; Rummeny EJ
    J Magn Reson Imaging; 1999 May; 9(5):643-52. PubMed ID: 10331759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing permeability alterations of the blood-bone marrow barrier due to total body irradiation: in vivo quantification with contrast enhanced magnetic resonance imaging.
    Daldrup-Link HE; Link TM; Rummeny EJ; August C; Könemann S; Jürgens H; Heindel W
    Bone Marrow Transplant; 2000 Jan; 25(1):71-8. PubMed ID: 10654018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow.
    Daldrup-Link HE; Rummeny EJ; Ihssen B; Kienast J; Link TM
    Eur Radiol; 2002 Jun; 12(6):1557-66. PubMed ID: 12042968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
    Simon G; Daldrup-Link H; von Vopelius-Feldt J; Wendland M; Fu Y; Schlegel J; Rummeny E
    Rofo; 2006 Feb; 178(2):200-6. PubMed ID: 16435251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superparamagnetic iron oxide (SPIO) MRI contrast agent for bone marrow imaging: differentiating bone metastasis and osteomyelitis.
    Fukuda Y; Ando K; Ishikura R; Kotoura N; Tsuda N; Kato N; Yoshiya S; Nakao N
    Magn Reson Med Sci; 2006 Dec; 5(4):191-6. PubMed ID: 17332709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging--feasibility study.
    Bierry G; Jehl F; Boehm N; Robert P; Prévost G; Dietemann JL; Desal H; Kremer S
    Radiology; 2008 Jul; 248(1):114-23. PubMed ID: 18458246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?].
    Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW
    Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study.
    Azoulay R; Olivier P; Baud O; Verney C; Santus R; Robert P; Gressens P; Sebag G
    J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of superparamagnetic iron oxide on bone marrow.
    Hundt W; Petsch R; Helmberger T; Reiser M
    Eur Radiol; 2000; 10(9):1495-500. PubMed ID: 10997443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
    Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model.
    Rendon DA; Kotedia K; Afshar SF; Punia JN; Sabek OM; Shirkey BA; Zawaski JA; Gaber MW
    J Nucl Med; 2016 Feb; 57(2):266-71. PubMed ID: 26315835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of intra- and perilienal tumors by use of a RES-specific MRI contrast agent].
    Gaffke G; Stroszczynski C; Gnauck M; Jost D; Chmelik P; Ludwig WD; Gretschel S; Felix R
    Rontgenpraxis; 2004; 55(5):192-9. PubMed ID: 15700656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of radiation-induced liver injury with MR imaging: comparison of hepatocellular and reticuloendothelial contrast agents.
    Clément O; Mühler A; Vexler VS; Rosenau W; Berthezène Y; Kuwatsuru R; Brasch RC
    Radiology; 1992 Oct; 185(1):163-8. PubMed ID: 1523301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.